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Surveillance for risk factors of cardiovascular disease among
an industrial population in southern India
V. MOHAN,  M. DEEPA,  S. FAROOQ,  D. PRABHAKARAN,  K. S. REDDY
ABSTRACT
Background. We assessed (i) the risk of cardiovascular
disease in an industrial population in Chennai, southern India and
(ii) whether the status of treatment and control of diabetes and
hypertension would be different in an industrial population,
which is provided free healthcare, compared with the general
population of Chennai.
Methods. Subjects residing in the residential areas of 2
industries (Indian Airlines and Integral Coach Factory) in Chennai
in southern India were recruited. The subjects were employees
(n=440) selected by an age- and sex-stratified random sampling
method, and their family members (n=727) in the age group
of 20–69 years; a total of 1167 subjects. Fasting plasma glucose,
lipid estimations and anthropometric measurements were done
in all the subjects. Information on demographic and lifestyle
determinants was obtained using a questionnaire. Diabetes was
diagnosed using the American Diabetes Association criteria
and metabolic syndrome was defined by the Adult Treatment
Panel III criteria with modified waist definition for Asian Indians.
Results. Age-adjusted prevalence of major risk factors for
cardiovascular disease using the 2001 Census of India were as
follows: diabetes 11.9%; hypertension 25.4%; dyslipidaemia
40.2%; hypertriglyceridaemia 28.3%; overweight (body mass
index ≥23 kg/m2) 60.2%; and metabolic syndrome 34.1%.
Use of tobacco in any form was present in 22.9% of men and
0.5% of women; 79% of the subjects followed a sedentary
lifestyle. Among subjects receiving medication, 42.1% of subjects
with diabetes and 55.3% of subjects with hypertension had their
disease under adequate control. A comparison of these results
with the general population of Chennai showed that the industrial
population had a higher prevalence of cardiovascular risk factors
in spite of having better access to healthcare facilities.
Conclusions. The prevalence of cardiovascular disease was
high in this industrial population of Chennai. Although the overall
treatment and control of diabetes and hypertension was better
than that in the general population, it was still inadequate and this
emphasizes the need for greater awareness about non-
communicable diseases.
Natl Med J India 2008;21:8–13
INTRODUCTION
Cardiovascular disease (CVD) is predicted to be the most common
cause of death globally, including in India, by 2020.1 The prevalence
of CVD and its risk factors are high in migrant people of Asian
Indian origin compared with the host population.2,3 The growing
burden of CVD4 is due to the increasing prevalence of cardiovascular
risk factors such as diabetes, hypertension, dyslipidaemia, overweight
or obesity, physical inactivity and use of tobacco. It is known that
CVD occurs at least a decade earlier in Asian Indians compared
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9with Europeans.5 India also perhaps suffers the highest loss in
potentially productive years of life, as deaths due to CVD in persons
in the age group of 35–64 years is high.6 It is predicted that by the
year 2015, India will have the largest burden of CVD in the world.7
Over time, the prevalence of many risk factors for CVD is also
likely to increase in developing countries due to higher levels of
smoking, overweight, diabetes and high blood pressure. A range of
factors contribute to this trend including the impact of
industrialization, urbanization, globalization and affluence.6 Further,
reversal of the social gradient (an inverse relationship of risk factors
of CVD to the level of socioeconomic status and education) has
been observed for certain risk factors (such as diabetes, impaired
glucose tolerance, hypertension, obesity, hypercholesterolaemia
and hyper-insulinaemia) in India. Hence, it would be useful to
assess the burden of risk factors for CVD among individuals with
a higher level of education than the general population and who
have access to healthcare. As Indians have a higher prevalence of
premature CVD, it would be useful to assess the prevalence of risk
factors of CVD in people in the working age group and in settings
where adequate healthcare facilities are available. This study was
designed to identify risk factors for CVD in an industrial population
in Chennai in southern India.
METHODS
Study design
The study was done in the residential colonies of Indian Airlines
and the Integral Coach Factory located in the metropolitan city of
Chennai (formerly Madras) in southern India, which has a
population of 5 million. Employees from these 2 industries and
their family members were selected based on the age- and sex-
stratified random sampling method (in each decile starting from
20–29 years to 60–69 years). The subjects included randomly
selected employees (n=440) and their eligible family members
(n=727) in the age group of 20–69 years, i.e. 1167 adults living in
the 2 colonies of these industries. A detailed questionnaire was
administered, anthropometric measurements were obtained and
biochemical estimations were done in all the eligible subjects. The
questionnaire obtained information regarding demographic and
lifestyle-related aspects associated with major risk factors of
CVD and their past medical history. All questions in the
questionnaire were tested in a pilot study for clarity and ‘face
validity’ (‘Does the question refer to what it intends to seek?’) and
then the final version of the questionnaire was developed. Also,
the questionnaire was pilot-tested for data quality and the questions
were modified and finalized based on the results of the pilot study.
The institutional ethics committee approved the study and
informed consent was obtained from all the subjects.
Fasting plasma glucose was measured in all the subjects. The
fasting blood sample was taken, after ensuring 8 hours of overnight
fasting, for estimation of plasma glucose and serum lipids using a
Hitachi 912 autoanalyser (Roche Diagnostics GmbH, Mannheim,
Germany). Anthropometric measurements including weight,
height, waist and hip measurements were obtained using
standardized techniques as described.
Height was measured with a tape to the nearest centimetre. The
subjects were asked to stand upright without footwear with their
back against the wall, heels together and eyes directed forward.
Weight was measured with a traditional spring balance that
was kept on a firm horizontal surface. Subjects were asked to wear
light clothing and weight was recorded to the nearest 0.5 kg.
Body mass index (BMI) was calculated using the formula:
weight (kg)/height (m)2.
Waist circumference was measured using a non-stretchable
measuring tape. The subjects were asked to stand erect in a relaxed
position with both feet together on a flat surface; one layer of
clothing was accepted. Waist girth was measured as the smallest
horizontal girth between the costal margins and the iliac crests at
minimal respiration.
Blood pressure was recorded in the sitting position in the right
arm to the nearest 1 mmHg using an electronic OMRON machine
(Omron Corporation, Tokyo, Japan). Two readings were taken
5 minutes apart and the mean of the 2 readings was used for analysis.
Definitions
Diabetes. The diagnosis of diabetes was based on the American
Diabetes Association (ADA) definition, i.e. fasting plasma glucose
≥126 mg/dl (≥7.0 mmol/L) or subjects who reported that they had
diabetes and were on treatment by a physician.8
Hypertension. Hypertension was diagnosed based on drug
treatment for hypertension or if the blood pressure was ≥140/90
mmHg (JNC-7 criteria).9
Dyslipidaemia. The National Cholesterol Education Programme
(NCEP) guidelines10 were used for the definition of dyslipidaemia.
Hypercholesterolaemia was diagnosed if the serum cholesterol
levels were ≥200 mg/dl (≥5.2 mmol/L) or if the subjects were
receiving drugs for the treatment of hypercholesterolaemia.
Hypertriglyceridaemia was diagnosed if serum triglyceride
levels were ≥150 mg/dl (≥1.7 mmol/L) or if the subjects were
receiving drugs for the treatment of hypertriglyceridaemia.
Low high-density lipoprotein (HDL) cholesterol was diagnosed
if HDL cholesterol levels were <40 mg/dl (<1.04 mmol/L) for
men and <50 mg/dl (<1.3 mmol/L) for women.
High low-density lipoprotein (LDL) cholesterol was diagnosed
if LDL cholesterol levels were >130 mg/dl (>3.3 mmol/L).
High total cholesterol (TC) to HDL cholesterol ratio (TC/
HDL) was diagnosed if the ratio was ≥4.5.
Metabolic syndrome was defined based on the National
Cholesterol Education Programme and Adult Treatment Panel III
(NCEP ATP III) criteria10 modified for waist circumference for
Asian Indians (as recommended by WHO for the Asia Pacific
region11) as the presence of 3 or more of the following risk factors:
fasting plasma glucose ≥110 mg/dl (>6.1 mmol/L), serum
triglyceride ≥150 mg/dl (>1.7 mmol/L), HDL cholesterol <40 mg/
dl (<1.0 mmol/L) in men and <50 mg/dl (<1.3 mmol/L) in women;
blood pressure ≥130/85 mmHg or waist circumference ≥90 cm in
men and ≥80 cm in women.
Physical activity was assessed using close-ended questions
probing self-perceived, self-reported type (occupational, domestic,
leisure time and transport related) during the past 5 years. The
intensity of physical activity was classified as ‘very light’ (walking,
job involving desk work, watching television), ‘light’ (standing
all day working, housework such as cooking, cleaning in the
house), ‘moderate’ (gardening, agricultural work, walking long
distances up and down hills, climbing more than 20 steps in a day),
and ‘heavy’ (lifting heavy weights, construction work, manual
labour and running).
Comparison with the general population
We compared the results of our study with the results of the
Chennai Urban Rural Epidemiology Study (CURES), which was
done in a representative population of adults >20 years of age in
Chennai. The detailed study design of CURES is described
elsewhere12 and the sampling frame is available at http://
www.drmohansdiabetes.com/mdrf/CURES.pdf.
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RESULTS
The mean (SD) age of the study population was 39.6 (11.2) years
(men: 41.1 [11.0] years and women: 38.2 [11.0] years). Among
the study population, 233 men (42.8%) and 180 women (29.2%)
were professionals, postgraduates or graduates (Table I). Only
0.4% of men and 1.8% of women were illiterate. Almost half the
men (42.9%) were involved in skilled or semi-skilled occupations,
followed by clerical jobs 33%; 11.9% were professionals and the
rest were either unskilled or unemployed. A majority of women
(80.7%) were homemakers. Among men (n=545), 22.9% were
current tobacco users; of these 21.3% smoked and 2.4% chewed
tobacco. Among women (n=622) only 1% reported using any
form of tobacco. None of the subjects reported the use of snuff.
Alcohol consumption was reported only by men and 40 of them
(7.8%) consumed alcohol regularly (at least 3 times a week) while
115 were occasional alcohol users (22.4%).
Only 2% of the subjects were involved in heavy physical
activities, 19% in moderate physical activity and 79% of the
population in either light or very light (sedentary) physical activity.
The major risk factors for CVD age-adjusted using the 2001
Census of India were diabetes 11.9%, hypertension 25.4%,
dyslipidaemia 40.2%, hypertriglyceridaemia 28.3%, metabolic
syndrome 34.1% and overweight 60.2%. The gender-wise age-
adjusted prevalence of risk factors of CVD showed that women
had a higher age-adjusted prevalence of overweight, central
obesity and metabolic syndrome compared with men (Fig. 1). The
age-adjusted prevalence of hypertension, hypertriglyceridaemia
and dyslipidaemia was higher in men than in women. The overall
prevalence of CVD was 2.1% (men 2.2%, women 2.1%) and the
prevalence of stroke was 0.2% in both men and women.
The prevalence of overweight, central obesity, hypertriglyceri-
daemia, high LDL cholesterol and dyslipidaemia increased with
age and either plateaued or decreased in older age groups (>60
years). The prevalence of diabetes, hypertension and metabolic
syndrome increased steadily until the age of 60 years and decreased
thereafter in both sexes (Table II).
Compared with women, men had significantly higher mean
systolic blood pressure (men 127 [16] mmHg, women 120 [19]
mmHg), diastolic blood pressure (men 80 [11] mmHg, women 77
[11] mmHg), waist circumference (men 87.9 [10.7] cm, women
84.0 [11.4] cm) and serum triglycerides (men 151 [108] mg/dl,
women 121 [89] mg/dl). Women had a significantly higher BMI
(men 24.1 [5.4] kg/m2, women 25.3 [4.7] kg/m2) and HDL
cholesterol (men 39 [9] mg/dl, women 45 [9] mg/dl). There was
no difference in the mean levels of fasting plasma glucose, total
cholesterol and LDL cholesterol between men and women. The
mean systolic blood pressure increased with age in both men and
women. The mean diastolic blood pressure, BMI, waist
circumference, fasting plasma glucose, cholesterol, triglycerides
and LDL cholesterol increased with age till the age of 60 years and
either decreased or plateaued thereafter. HDL cholesterol had no
linear relationship with age (Table III).
Among those with diabetes (n=120), 78% subjects admitted to
following the dietary modifications prescribed while 22% did
regular physical exercise. A majority of subjects (88.2%) were
receiving allopathic drugs (78% oral hypoglycaemic drugs and
10.2% insulin), 19.5% were on traditional treatment and 1.7%
were not receiving any treatment for diabetes (some subjects were
receiving more than one form of treatment). Among the subjects
who had hypertension (n=134), 65.2% were on allopathic drugs,
16.7% on traditional treatment and 1.5% were not receiving any
treatment (Fig. 2). Among those on medication, 83.9% of subjects
TABLE I. Characteristics of the study population
Variable Total Men Women
(n=1167) (n=545) (n=622)
Mean (SD) age (years) 39.6 (11.2) 41.1 (11.0) 38.2 (11.0)
Age group in years (%)
20–29 19.3 16.8 21.5
30–39 31.6 26.6 36.1
40–49 29.8 31.9 27.9
50–59 15.1 21.4 9.5
≥60 4.2 3.3 5.1
Total 100 46.7 53.3
Education (%)
Professional/postgraduate/graduate 35.5 42.8 29.2
Secondary school 60.2 55.2 64.7
Up to primary/literate 3.1 1.7 4.4
Illiterate 1.1 0.4 1.8
Occupation (%)
Professional 6.6 11.9 1.9
Trained/clerical 20.4 33.0 9.2
Skilled/semi-skilled 20.7 42.9 1.1
Unskilled 0.3 0.7 0
Unemployed 9.0 11.4 7.0
Housewife 42.9 0 80.7
Tobacco use (%)
Ever used 16.7 35.0 0.5
Current use* 11.0 22.9 0.5
Current smoking 10.0 21.3 0
Current chewing 1.4 2.4 0.5
Alcohol (%)
Never used 86.3 69.8 100
Current regular use† 3.5 7.8 0
Current occasional use‡ 10.2 22.4 0
Physical activity (%)
Very light 3.9 4.2 3.6
Light 75.2 73.5 76.7
Moderate 19.0 19.3 18.7
Heavy 1.9 2.9 1.0
Self-reported diabetes (%) 10.3 12.1 8.7
Self-reported hypertension (%) 11.5 13.0 10.1
* use of tobacco products in any form in previous 30 days  † alcohol intake more
than 3 times (average) a week ‡ alcohol intake more than 3 times a month, but less
than 3 times a week
with diabetes and 78.8% of those with hypertension were on
regular medication. While 74.6% of subjects (n=88) with diabetes
perceived themselves to be under good glycaemic control, 69.7%
(n=92) of hypertensive subjects perceived their blood pressure to
be under good control. However, the results of the fasting blood
glucose and blood pressure measurements showed that of those on
medication, only 42.1% of those with diabetes and 55.3% of those
with hypertension were under adequate control (i.e. fasting blood
glucose <140 mg/dl for diabetic subjects and systolic/diastolic
blood pressure <140/90 mmHg for hypertensive subjects).
A comparison of our results with those from the general
population of Chennai showed that the prevalence of hypertension,
generalized obesity and metabolic syndrome was higher compared
with the general population while the prevalence of dyslipidaemia
was comparable (Table IV). The awareness and control of hyper-
tension was better among our subjects compared with the general
population.
DISCUSSION
We studied the prevalence of risk factors for CVD in an industrial
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FIG 1. Age-adjusted prevalence of risk factors for cardiovascular
disease in an industrial population
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TABLE II. Prevalence of overweight, central obesity, dyslipidaemia, diabetes, hypertension and metabolic syndrome in different age groups
Variable 20–29 years 30–39 years 40–49 years 50–59 years >60 years Total
Men Women Men Women Men Women Men Women Men Women Men Women
Body mass index
> 23 kg/m2 29 (33.0) 58 (47.2) 96 (67.6) 163 (75.1) 113 (66.9) 122 (75.3) 75 (66.4) 47 (81.0) 7 (41.2) 20 (69.0) 320 (60.5) 410 (69.6)
> 25 kg/m2 16 (17.8) 32 (26.0) 56 (40.0) 121 (56.0) 67 (39.4) 99 (60.7) 51 (44.7) 36 (62.1) 4 (22.2) 18 (62.1) 194 (36.5) 306 (52.0)
Central obesity* 14 (15.6) 28 (22.4) 61 (43.0) 116 (53.0) 92 (53.8) 89 (54.6) 64 (55.7) 33 (56.9) 7 (38.9) 19 (65.5) 238 (44.4) 285 (47.9)
TC/HDL >4.5† 20 (33.9) 13 (17.8) 49 (53.8) 40 (27.8) 65 (63.1) 32 (34.8) 34 (50.7) 11 (37.9) 5 (62.5) 6 (37.5) 173 (52.7) 102 (28.8)
Triglycerides 13 (22.0) 4 (5.5) 41 (45.1) 28 (19.4) 42 (40.8) 25 (27.2) 22 (32.8) 12 (41.4) 3 (37.5) 9 (56.3) 121 (36.9) 78 (22.0)
> 150 mg/dl
LDL cholesterol 12 (20.3) 9 (12.3) 14 (15.4) 26 (17.9) 31 (29.8) 23 (25.0) 20 (30.3) 14 (48.3) 5 (62.5) 4 (26.7) 82 (25.0) 76 (21.5)
> 130 mg/dl
Diabetes‡ 1 (1.1) 2 (1.5) 12 (8.2) 14 (6.3) 31 (17.9) 28 (16.4) 33 (28.4) 20 (33.3) 4 (22.2) 8 (25.8) 81 (14.9) 72 (11.6)
Hypertension§ 11 (12.0) 4 (3.0) 37 (25.3) 21 (9.4) 58 (33.5) 62 (36.3) 67 (57.8) 32 (53.3) 6 (33.3) 19 (61.3) 179 (32.8) 138 (22.3)
Metabolic 8 (13.6) 5 (6.8) 32 (35.2) 38 (26.8) 44 (43.1) 45 (48.9) 31 (47.0) 22 (78.6) 4 (50.0) 12 (75.0) 119 (36.5) 122 (34.8)
syndrome||
* waist circumference >90 cm in men and >85 cm in women  †TC/HDL total cholesterol to high-density lipoprotein cholesterol ratio  ‡ fasting plasma glucose >126 mg/dl
or drug treatment for diabetes mellitus  § systolic blood pressure >140 mmHg or diastolic blood pressure >90 mmHg or under medication for hypertension  || based on NCEP
ATP III criteria: NCEP ATP III guidelines define metabolic syndrome based on presence of any three of the following five components: abdominal obesity, elevated triglycerides, low
HDL cholesterol, raised blood pressure and impaired fasting glucose level  Values in parentheses are percentages
TABLE III. Age-specific blood pressure, body mass index, waist circumference and lipid levels in our study population
Variable 20–29 years 30–39 years 40–49 years 50–59 years >60 years Total
Men Women Men Women Men Women Men Women Men Women Men Women
Blood pressure (mmHg)
Systolic 123 (11) 110 (10) 125 (13) 115 (14) 126 (17) 126 (20) 132 (20) 135 (25) 134 (16) 143 (20) 127 (16) 120 (19)
Diastolic 74 (8) 71 (8) 80 (11) 76 (10) 81 (11) 81 (11) 84 (12) 82 (10) 78 (7) 82 (11) 80 (11) 77 (11)
Body mass 21.5 (3.9) 22.7 (4.4) 24.5 (3.0) 25.8 (4.5) 25 (8.1) 26 (4.7) 24.6 (3.1) 26.1 (4.1) 22.9 (3.0) 27.2 (5.3) 24.1 (5.4) 25.3 (4.7)
index (kg/m2)
Waist circum- 78.5 (11.2) 77.5 (11.4) 88.7 (8.5) 85.0 (10.4) 90 (10.4) 85.8 (10.4) 91.2 (9.7) 86.9 (11.4) 86.6 (7.8) 89.4 (12.8) 87.9 (10.7) 84.0 (11.4)
ference (cm)
Fasting plasma 84 (8) 88 (9) 94 (17) 96 (30) 108 (44) 109 (40) 117 (42) 135 (67) 96 (15) 120 (39) 101 (35) 102 (37)
glucose (mg/dl)
Cholesterol 166 (36) 162 (27) 177 (32) 171 (31) 186 (41) 189 (38) 184 (40) 197 (30) 183 (46) 194 (35) 179 (38) 177 (34)
(mg/dl)
Triglycerides 108 (57) 83 (36) 167 (109) 112 (62) 158 (97) 138 (73) 155 (144) 140 (56) 138 (90) 238 (288) 151 (108) 121 (89)
(mg/dl)
HDL cholesterol 42 (9) 47 (9) 38 (9) 44 (9) 38 (8) 46 (10) 40 (10) 46 (9) 38 (9) 43 (7) 39 (9) 45 (9)
(mg/dl)
LDL cholesterol 102 (30) 99 (25) 105 (27) 105 (27) 116 (36) 116 (33) 116 (36) 123 (25) 117 (35) 110 (33) 111 (33) 108 (30)
(mg/dl)
HDL high-density lipoprotein  LDL low-density lipoprotein  All values are mean (SD)
FIG 2. Type of treatment taken by subjects with diabetes and
hypertension
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population of Chennai. Our study presents the ‘best case scenario’
because the industries offer free healthcare to their employees.
The study assumes importance as it answers the question:
‘What would be the state of risk factors for CVD and the status
of treatment of diabetes and hypertension in India if there were
no financial constraints to healthcare?’ As most healthcare
expenditure in India (>80%) is ‘out of pocket’, optimal healthcare
is not accessible to a large population in India. The argument
therefore is that if there were no financial constraints, healthcare
would be optimum. The key findings of our study are that in this
industrial population the prevalence of most risk factors for CVD
is high and the number of people engaged in physical activity is
very low. Among those with known diabetes and hypertension on
treatment, 80% were reported to be on regular medication.
Asian Indians develop diabetes a decade earlier than
Europeans2 with the most marked increase in prevalence being
among those in the productive age group. In a large epidemio-
logical study done on a representative population of Chennai
(CURES), it was seen that >10% of individuals in the age group
of 30–39 years and 20% of individuals in the age group of 40–
49 years had diabetes.13 The Indian Council of Medical Research
(ICMR) Sentinel Surveillance Systems for CVD in Indian
industrial populations, involving 10 centres from different parts
of India, documented a 10.1% overall prevalence of diabetes in
the age group of 20–69 years.14 In our study, which is also part
of the study mentioned above, the age-standardized prevalence
of diabetes (11.9%) was slightly higher than that reported in
other studies. Also, the high prevalence of self-reported diabetes
(10.3%) in our study shows the high level of health awareness of
this industrial population and the excellent healthcare facilities
available to them. Differences in access to healthcare can have
far-reaching consequences. In addition, several other factors
influence the health of a population including socioeconomic
status, urbanization and lifestyle changes. Though healthcare
facilities are overwhelmingly concentrated in urban areas, the
‘socioeconomic distance’ prevents access to these for the urban
poor. One of our earlier studies showed that significant differences
exist in the prevalence of various components of the metabolic
syndrome even within an urban environment and this appears to
be influenced by the socioeconomic status.15
The age-adjusted prevalence of hypertension (25.4%) in our
study was similar to that seen at the other 10 centres in India in the
ICMR sentinel surveillance project (26%).14 The prevalence of
hypertension in this industrial population was also higher than
that reported in population-based studies in Chennai (the Chennai
Urban Population Study 21.1%16 and CURES 20%17). In CURES,
among subjects with hypertension, 32.8% were aware of their
condition; of these, 70.8% were under treatment and 45.9% had
their blood pressure under control.17 Thus, compared with the
general population of Chennai, this industrial population was
more aware of hypertension and control of blood pressure.
However, this may be because this population was more affluent
than the general population of Chennai.
In our study, the age-adjusted prevalence of overweight (BMI
>23 kg/m2) was 60.2%. The age-adjusted prevalence of overweight
(BMI >23 kg/m2) among the industrial population in the ICMR
sentinel surveillance project of 10 Indian industrial centres was
46.7%.14 As reported in the sentinel project, the overall prevalence
of overweight (BMI >25 kg/m2) was lowest in Assam (0.5%)
and highest in Hyderabad (50%). Among the industrial popula-
tions of Bangalore, Trivandrum and Coimbatore, the prevalence
rates of overweight (BMI >25 kg/m2) were 47%, 38% and 27%,
respectively.18 The overall prevalence of overweight (BMI >25
kg/m2) in our study was 44.5%. The sedentary job profile of the
subjects may be the reason for the high rates of overweight in this
population.
Central or abdominal obesity was present in 32% of the
industrial population in the ICMR sentinel surveillance project
among all 10 centres and the highest prevalence was reported from
Hyderabad (52%). The population of Bangalore, Trivandrum and
Coimbatore had prevalence rates of 45%, 32% and 41%,
respectively.18 In our study, the prevalence of central obesity was
42.1% while in the CURES study it was 49.2% in the urban
population of Chennai.19
The ICMR sentinel surveillance project observed the prevalence
of dyslipidaemia to be 37.5% in individuals in the age group of
15–64 years and 62% among individuals in the age group of
20–59 years.14 In our study, dyslipidaemia was present in 40.2%
of those in the age group of 20–69 years.
The age-adjusted prevalence of metabolic syndrome in this
study was 34.1%, which is higher than that reported by the ICMR
sentinel surveillance project (24.8%).14 In CURES, the prevalence
of metabolic syndrome was 23.2% by the WHO criteria, 18.3% by
the ATP III criteria and 25.8% by the International Diabetes
Federation criteria,20 which were all less than that in our study.
The reason for this higher prevalence may be the sedentary
lifestyle of the subjects.
Based on the subjects’ perceived daily physical activity, the
physical activity levels were generally low in our study, with 79%
of subjects involved in very light or light physical activity. In the
ICMR sentinel surveillance project, 13%, 51.4% and 35.6% of the
industrial population were involved in heavy, moderate and light
physical activity.14 This suggests the need for increasing awareness
about the benefits of physical activity.
The National Household Survey of Drug and Alcohol Abuse in
India (NHSDAA) on 40 000 men in 25 states documented the
overall prevalence of current tobacco use to be 54.9% in those in
the age group of 19–30 years, 67.6% among 31–40 years and 72%
among those 41–60 years.21 The prevalence of tobacco use among
individuals >15 years of age according to the National Sample
Survey (NSS) was 51.3% in men and 10.3% in women and, based
on the National Family Health Survey-2 (NFHS-2), it was 46.5%
in men and 13.8% in women.21 In the ICMR sentinel surveillance
project, the prevalence of current tobacco use was 40.2% among
men and 14.9% among women.14 In our study, 22.9% of men and
0.5% of women were current tobacco users; these figures are
comparatively lower than those reported earlier.
A range of factors contribute to the increasing trend in risk
factors for CVD. Compared with other countries, India has the
TABLE IV. Comparison of percentage prevalence of cardiovascular
risk factors in this study and in the general population (CURES
study)
Cardiovascular risk factors Present study General population
(n=1167) (CURES) (n=2350)
Diabetes 11.9 14.3
Hypertension 25.4 20.o
Awareness 42.3 32.8
Treatment 66.7 70.8
Control 55.2 45.9
Generalized obesity 44.5 28.1
Abdominal obesity 42.1 49.2
Dyslipidaemia 40.2 41.o
Metabolic syndrome 34.1 18.3
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highest loss in potentially productive years of life due to deaths
from CVD in people 35–64 years of age.6 The higher rates of risk
factors for CVD in this relatively young population from southern
India is alarming and preventive measures need to be initiated. It
also suggests that though healthcare is better in this industrial
population compared with the general population, it is still
inadequate. It underscores the need for increasing awareness of
non-communicable diseases even in populations that have access to
free healthcare. The inaccessibility of healthcare facilities has
affected the utilization of modern healthcare services by a majority
of people in India. However, the results of this study highlight that
in addition to accessibility, there are factors such as health awareness
and involvement in physical activity which play a major role in
combating CVD and thereby improve the quality of life.
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